Lupin Launches COVID-19 Drug Favipiravir In India At Rs 49 Per Tablet - NDTV 06-Aug-2020

Lupin Launches COVID-19 Drug Favipiravir In India At Rs 49 Per Tablet - NDTV


Drug major Lupin on Wednesday announced the launch of its Favipiravir drug under the brand name "Covihalt" for the treatment patients with mild to moderate COVID-19 symptoms at Rs 49 per tablet in India.

More...